Download presentation
Presentation is loading. Please wait.
1
Calcium regulation on actinin by Cynthia Santoso Dr. Jeffrey Greenwood Lab Biochemistry and Biophysics Department
2
Cancer Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. If the spread is not controlled, it can result in death.
3
Cancer Cancer is caused by both: Cancer is caused by both: external factors (tobacco, chemicals, radiation, infectious organisms) external factors (tobacco, chemicals, radiation, infectious organisms) Internal factors (inherited mutations, hormones, immune conditions, and mutations that occur from metabolism) Internal factors (inherited mutations, hormones, immune conditions, and mutations that occur from metabolism)
4
Who is at risk of developing cancer? ANYONE. ANYONE. Since occurrence of cancer increases as individuals age, most cases affect adults beginning in middle ages. Since occurrence of cancer increases as individuals age, most cases affect adults beginning in middle ages.
5
Cancer Types of cancer: Types of cancer: Benign tumor Benign tumor - Remains confined to its original location, neither invading surrounding normal tissue nor spreading to distant body sites. Malignant tumor Malignant tumor - Capable of both invading surrounding normal tissue and spreading throughout the body via the circulatory or lymphatic system.
6
Cancer Only malignant tumors are properly referred as cancers, and it is the ability to invade and metastasize that makes cancer so dangerous. Only malignant tumors are properly referred as cancers, and it is the ability to invade and metastasize that makes cancer so dangerous. * metastasis refers to the spread of cancer cells from their site of origin to other sites in the body.
7
Metastasis The very important process by which cancer spreads from one part of the body to another. How do these cancer cells move about?
8
Metastasis Moving cells, whether healthy or cancerous, grab the extracellular matrix with tiny feet, called focal adhesion complexes. Moving cells, whether healthy or cancerous, grab the extracellular matrix with tiny feet, called focal adhesion complexes. They move their way up along the extracellular matrix. They move their way up along the extracellular matrix. Upon reaching a vein or artery, they have a long trip throughout the body. Upon reaching a vein or artery, they have a long trip throughout the body. At the end of the journey, they exit the blood vessel and found a new location to further grow. At the end of the journey, they exit the blood vessel and found a new location to further grow.
9
Cell Adherence Cell adhesion is an important mechanism by which cells interact with the extracellular environment. Cell adhesion is an important mechanism by which cells interact with the extracellular environment. The adhesive state of a cell has significant influence on growth and survival, migration, and signal transduction. The adhesive state of a cell has significant influence on growth and survival, migration, and signal transduction. Attached Cell Spread Cell Cell with stress fibers and focal adhesions Weak Adherence Intermediate Adherence Strong Adherence De-adhesion
10
Focal Adhesion Structure Talin Vinculin Paxillin Talin -actinin FAK Syndecan-4 Extracellular Matrix
11
Strong Adherence - cell with stress fibers and focal adhesions Intermediate Adherence PI 3-kinasePDGF P T T P T -a T V V V V = PtdIns (3,4,5)-P 3 PDGF treated fibroblasts
12
Hallmark of cell adhesion and motility studies It enables us to modulate or adjust or vary these signals in order to control both desirable and undesirable cell growth and motility. It enables us to modulate or adjust or vary these signals in order to control both desirable and undesirable cell growth and motility.
13
Alpha-actinin structure -actinin is an anti-parallel homodimer. -actinin is an anti-parallel homodimer. Each monomer is composed of three domains: Each monomer is composed of three domains: The actin-binding domain The actin-binding domain The spectrin repeats The spectrin repeats The C-terminal EF hands domain The C-terminal EF hands domain ABD Spectrin repeats EF hands 4321 1234 CH1 CH2 CH1 1256364479600713887141
14
Fact It has been known that calcium regulates actinin bundling activity. It has been known that calcium regulates actinin bundling activity. “Calcium oscillation trigger focal adhesion disassembly…” by Giannone et al. “Calcium oscillation trigger focal adhesion disassembly…” by Giannone et al.
15
Question 1. Do the EF Hands domains bind specifically to the Actin-binding domains? 2. If so, is the binding regulated by Calcium ion? 2. If so, is the binding regulated by Calcium ion?
16
The Young et al Hypothesis The closed or inactive state of the molecule exists when the EF 3/4 region of the CaM-like region of the CaM-like domain interacts with a region between the ABD and R1 of the opposite subunit. The closed or inactive state of the molecule exists when the EF 3/4 region of the CaM-like region of the CaM-like domain interacts with a region between the ABD and R1 of the opposite subunit. Ca2+
17
The Tang et al Hypothesis In the presence of Ca2+, the CAL domain (EF Hands) of -actinin could undergo a conformational change that enables it to wrap around… the connecting helix between the two CH domains in the ABD. In the presence of Ca2+, the CAL domain (EF Hands) of -actinin could undergo a conformational change that enables it to wrap around… the connecting helix between the two CH domains in the ABD. Ca 2+
18
Method Protein-protein overlay assay. Protein-protein overlay assay. We did overlay with the full length of - actinin. We did overlay with the full length of - actinin.
19
Protein-Protein Overlay Assay 1° antibody2° antibody Enhanced Chemiluminescence
20
Protein-Protein Overlay Assay 4 membranes that are treated differently 4 membranes that are treated differently Membrane #1: CaCl 2 (presence of Ca 2+ ) Membrane #1: CaCl 2 (presence of Ca 2+ ) Membrane #2: EGTA (absence of Ca 2+ ) Membrane #2: EGTA (absence of Ca 2+ ) Membrane #3: control for buffer Membrane #3: control for buffer Membrane #4: control for antibodies Membrane #4: control for antibodies
21
GST 1 2 3 MW + EGTA+ CaCl2 + nothingno GST-CaM (Control) Lane #: 1: 1.25 ug -a 2: 2.5 ug -a 3: 5 ug -a MW: molecular weight standard GST: control for antibody
23
Protein-Protein Overlay 1° antibody2° antibody Enhanced Chemiluminescence
24
1° antibody2° antibody Enhanced Chemiluminescence Protein-Protein Overlay
26
The Young et al hypothesis is supported. 1269 218749 Common domain: the linker domain
28
Protein-Protein Overlay 1° antibody2° antibody Enhanced Chemiluminescence
29
1° antibody2° antibody Enhanced Chemiluminescence Protein-Protein Overlay
31
The Tang et al hypothesis is supported. 1269 218749 Lacks the complete region of Actin-binding domain, therefore there is no sign of binding.
32
Problem encountered Fragments of -actinin in stock are: Fragments of -actinin in stock are: GST 713887 GST 1269 CH2 CH1 ABD 218 GST 749 4321
33
Problem encountered If we do the protein-protein overlay, we might expect the If we do the protein-protein overlay, we might expect the 1° antibody to recognize the GST tag of actinin fragment. GST 1269 CH2 CH1
34
Problem encountered 1° antibody2° antibody Enhanced Chemiluminescence
35
1269 218749 1269 218749 Thrombin CleanCleave Kit -actinin fragments. Used Thrombin CleanCleave Kit to cleave the GST- tag off of the -actinin fragments.
36
Products of the Cleavage Reaction GST- -actinin (1-269) -actinin (1-269) ~30 kDa GST- ~27 kDa Molecular weight
37
Fragments of alpha actinin 4321 1234 CH1 CH2 CH1 1269 2187491887 713 887
38
Current progress I am using the cleaved -actinin fragments to do more experiments. I am using the cleaved -actinin fragments to do more experiments.
39
Acknowledgement Howard Hughes Medical Institute Environmental Health Science Center Dr. Jeffrey Greenwood Dr. Kevin Ahern Corey Singleton Tamara Fraley Thuan Tran Scott Viner
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.